Literature DB >> 20627072

Tumors as organs: complex tissues that interface with the entire organism.

Mikala Egeblad1, Elizabeth S Nakasone, Zena Werb.   

Abstract

Solid tumors are not simply clones of cancer cells. Instead, they are abnormal organs composed of multiple cell types and extracellular matrix. Some aspects of tumor development resemble processes seen in developing organs, whereas others are more akin to tissue remodeling. Some microenvironments, particularly those associated with tissue injury, are favorable for progression of mutant cells, whereas others restrict it. Cancer cells can also instruct surrounding tissues to undergo changes that promote malignancy. Understanding the complex ways in which cancer cells interact with their surroundings, both locally in the tumor organ and systemically in the body as a whole, has implications for effective cancer prevention and therapy. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20627072      PMCID: PMC2905377          DOI: 10.1016/j.devcel.2010.05.012

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  181 in total

Review 1.  The stem-cell niche as an entity of action.

Authors:  David T Scadden
Journal:  Nature       Date:  2006-06-29       Impact factor: 49.962

2.  Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.

Authors:  Markus Loeffler; Jörg A Krüger; Andreas G Niethammer; Ralph A Reisfeld
Journal:  J Clin Invest       Date:  2006-06-22       Impact factor: 14.808

Review 3.  Nuclear factor-kappaB in cancer development and progression.

Authors:  Michael Karin
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

Review 4.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.

Authors:  Jing Yang; Robert A Weinberg
Journal:  Dev Cell       Date:  2008-06       Impact factor: 12.270

Review 5.  The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance.

Authors:  Mark B Meads; Lori A Hazlehurst; William S Dalton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

6.  Regulation of in situ to invasive breast carcinoma transition.

Authors:  Min Hu; Jun Yao; Danielle K Carroll; Stanislawa Weremowicz; Haiyan Chen; Daniel Carrasco; Andrea Richardson; Shelia Violette; Tatiana Nikolskaya; Yuri Nikolsky; Erica L Bauerlein; William C Hahn; Rebecca S Gelman; Craig Allred; Mina J Bissell; Stuart Schnitt; Kornelia Polyak
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

Review 7.  Integrins in angiogenesis and lymphangiogenesis.

Authors:  Christie J Avraamides; Barbara Garmy-Susini; Judith A Varner
Journal:  Nat Rev Cancer       Date:  2008-05-22       Impact factor: 60.716

8.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 9.  The role of myeloid cells in the promotion of tumour angiogenesis.

Authors:  Craig Murdoch; Munitta Muthana; Seth B Coffelt; Claire E Lewis
Journal:  Nat Rev Cancer       Date:  2008-07-17       Impact factor: 60.716

10.  "Re-educating" tumor-associated macrophages by targeting NF-kappaB.

Authors:  Thorsten Hagemann; Toby Lawrence; Iain McNeish; Kellie A Charles; Hagen Kulbe; Richard G Thompson; Stephen C Robinson; Frances R Balkwill
Journal:  J Exp Med       Date:  2008-05-19       Impact factor: 14.307

View more
  428 in total

1.  Cancer therapeutics: time to swim downstream?

Authors:  Richard Steinman
Journal:  Oncologist       Date:  2011

2.  Intradomain cleavage of inhibitory prodomain is essential to protumorigenic function of membrane type-1 matrix metalloproteinase (MT1-MMP) in vivo.

Authors:  Vladislav S Golubkov; Andrei V Chernov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

Review 3.  Tissue biology perspective on macrophages.

Authors:  Yasutaka Okabe; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

4.  Feeding cancer's sweet tooth: specialized tumour vasculature shuttles glucose in pancreatic ductal adenocarcinoma.

Authors:  Andrew C Dudley; Victoria L Bautch
Journal:  J Pathol       Date:  2015-03-30       Impact factor: 7.996

5.  A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer.

Authors:  Dong-Joo Cheon; Yunguang Tong; Myung-Shin Sim; Judy Dering; Dror Berel; Xiaojiang Cui; Jenny Lester; Jessica A Beach; Mourad Tighiouart; Ann E Walts; Beth Y Karlan; Sandra Orsulic
Journal:  Clin Cancer Res       Date:  2013-11-11       Impact factor: 12.531

Review 6.  Influence of tumour micro-environment heterogeneity on therapeutic response.

Authors:  Melissa R Junttila; Frederic J de Sauvage
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

7.  The independent roles of mechanical, structural and adhesion characteristics of 3D hydrogels on the regulation of cancer invasion and dissemination.

Authors:  Jennifer N Beck; Anirudha Singh; Ashley R Rothenberg; Jennifer H Elisseeff; Andrew J Ewald
Journal:  Biomaterials       Date:  2013-09-14       Impact factor: 12.479

Review 8.  Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutases.

Authors:  Aaron K Holley; Lu Miao; Daret K St Clair; William H St Clair
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

9.  In vivo detection of drug-induced apoptosis in tumors using Raman spectroscopy.

Authors:  Oliver Jonas; Jeon Woong Kang; Surya P Singh; Alex Lammers; Freddy T Nguyen; Ramachandra R Dasari; Peter T C So; Robert Langer; Michael J Cima
Journal:  Analyst       Date:  2018-10-08       Impact factor: 4.616

10.  Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research.

Authors:  David H Lum; Cindy Matsen; Alana L Welm; Bryan E Welm
Journal:  Curr Protoc Pharmacol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.